Thionucleoside derivative or salt thereof, and pharmaceutical composition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10059734
APP PUB NO 20170233429A1
SERIAL NO

15581834

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are a compound and a pharmaceutical composition that exhibit an excellent drug efficacy against a tumor, in particular a tumor which has acquired resistance to gemcitabine. Specifically, provided is a thionucleoside derivative represented by General Formula [1]

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • FUJIFILM CORPORATION

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kuniyoshi, Hidenobu Ashigarakami-gun, JP 9 57
Matsumoto, Takuya Ashigarakami-gun, JP 307 3443
Nakagawa, Daisuke Ashigarakami-gun, JP 53 456
Yoshimitsu, Yuji Ashigarakami-gun, JP 8 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 28, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 28, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00